anx_II__cpt_1__cpt_1__cpt_1__table_1__row_91

Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products Text with EEA relevance · European Union

8.7.2. By inhalation Testing by the inhalation route is appropriate if exposure of humans via inhalation is likely taking into account: the vapour pressure of the substance (a volatile substance has vapour pressure > 1 × 10^(–2) Pa at 20 °C) and/or the active substance is a powder containing a significant proportion (e.g. 1 % on a weight basis) of particles with particle size MMAD < 50 micrometers or the active substance is included in products that are powders or are applied in a manner that generates exposure to aerosols, particles or droplets of an inhalable size (MMAD < 50 micrometers) the Acute Toxic Class Method is the preferred method for the determination of this endpoint

← anx_II__cpt_1__cpt_1__cpt_1__table_1__row_90__cell_3 · All articles · anx_II__cpt_1__cpt_1__cpt_1__table_1__row_91__cell_1 →

Source: EUR-Lex (Cellar) · retrieved 2026-10-29 · Text as adopted (Official Journal); later amendments are not incorporated in this text.